Pharvaris N.V. (PHVS) Stock

About Pharvaris N.V.

Pharvaris N.V. (PHVS) stock trades at $31.41 with a market capitalization of $2.19B. The stock is valued at a negative price-to-earnings (P/E) ratio of -10.26, reflecting a net loss over the last twelve months, price-to-book of 6.27, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $20.65 and $43.25, and currently trades 27.4% below its 52-week high.

On profitability, Pharvaris N.V. generates a return on equity (ROE) of -61.24% (negative, reflecting a net loss), return on capital employed of -60.76%.

Pharvaris N.V. by the numbers, 2017–2025

Compounded, revenue has grown —% a year over five years, —% over three, —% over the last twelve months. Net profit was $-176.0M in 2025.

On a trailing twelve-month basis to Jun '26, revenue is $0 and net profit $-172.0M.

Borrowings stand at $1.0M, cash from operations was $-137.0M in the latest year, positive in 0 of the last 9.

Return on equity has averaged -42.6% over five years, and was -64.9% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Pharvaris N.V. (PHVS) — frequently asked questions